Tiltan attacks cancer using four different materials
The company has developed a method for applying transgenic tobacco to produce human recombinant collagen.
CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement
Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis
Four years after the first information on featherless broiler research was known, the attention of the public and world media was attracted. Commercial trials show the big advantage over their feathered relatives, especially when kept in tropical regions.
Bioline will develop a new drug based on the technology of Prof. Hillel Bercovier and Dr. Ayelet Barenholz of the Hebrew university.
The agreement is reportedly worth several million dollars.
Yissum subsidiary Target-In and Indian company Century Pharmaceuticals will jointly develop a new drug for asthma and allergy, which will be based on the molecule developed by the Israel company.
(Hebrew article attached)
A facility for cross-disciplinary scientific research on a more comprehensive scale than has been
attempted anywhere is being launched by the Hebrew University of Jerusalem, in cooperation
with Yissum, the technology transfer company of the university.
These yellow cherry tomato seeds, named Summer Sun, were developed by Hazera
Genetics, part of the French-based global group Vilmorin Clause & Cie, in
collaboration with the Faculty of Agriculture at the Hebrew University.
This grant was received from the World Fund for Juvenile Diabetes Research and D-Cure. (Hebrew article attached)
Yissum will aid Kazakhstan in establishing technology transfer facilities as part of the Kazakhstan National Center for Biotechnology. (Hebrew article attached)
Biocancell Therapeutics Ltd.’s IPO benefited from both investor confidence in the company and lucky timing. Scheduled during the war, it was held on the day the cease-fire went into effect, when trading on the Tel Aviv Stock Exchange (TASE) was mixed.
An Israeli university that numbers physicist Albert Einstein among its founders has become a
crucible on transforming research into successful products.
It is one of the largest patent filers in
the world, holds a bigger portfolio
than most venture funds, is parent to 60
spin-off companies and originates a billion
dollars in product sales each year...
A small Israeli company has been tapping
into the knowledge of some of the best
scientific minds in the country for more than
forty years in order to bring forth new and
In research conducted at the Hebrew University, a
method for controlling bacterial activity without
antibiotics was developed. The research showed
how it is possible to interfere with the
communication of groups of bacteria thus enabling
new ways of fighting bacterial infections and
disease caused by germs as well as ways to help
beneficial bacteria to multiply.
A novel, computer-assisted method for colorizing black and white images
and movies has been developed by researchers at the Hebrew University
of Jerusalem. The new colorization method can significantly reduce the
time it takes to colorize still and video images and may also be
incorporated in future image and video editing software at the consumer
Israeli and German scientists have successfully created artificial silk
using genetically engineered spider proteins. The new research may
lead the way to the development of ultra light bulletproof vests, new
surgical threads and micro-conductors, optical fibers and even new
types of clothing.
An Israeli company has
developed a computer
algorithm that can identify a
persons musical taste and
then recommend music
specifically tailored to that